RBC Capital maintains Sector Perform on Pacira BioSciences, $36.50 target
RBC Capital maintained a Sector Perform rating on Pacira BioSciences and kept its $36.50 price target, roughly in line with the Oct. 8 close of $36.39.
Story updates
02:56:17 PM UTC
SquawkNews
Pacira BioSciences Is Maintained at Sector Perform by RBC Capital